The GH-IGF-I axis in children with idiopathic short stature

被引:32
作者
Blair, JC [1 ]
Savage, MO [1 ]
机构
[1] St Bartholomews & Royal London Sch Med & Dent, Dept Endocrinol, Sect Paediat Endocrinol, London EC1A 7BE, England
关键词
D O I
10.1016/S1043-2760(02)00631-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Idiopathic short stature (ISS) is a term used for children in whom the etiology of the short stature is undefined. Investigations of the growth hormone (GH)-insulin-like growth factor I axis have revealed several molecular and endocrinological defects in ISS patients. Abnormalities of GH secretion and action, although not frequent, will help to categorize some children with ISS. Because most diagnostic methods remain crude, however, their modification might be necessary to identify more subtle and yet functionally significant abnormalities of this endocrine axis.
引用
收藏
页码:325 / 330
页数:6
相关论文
共 73 条
[1]   Peak and trough growth hormone (GH) concentrations influence growth and serum insulin like growth factor-1 (IGF-1) concentrations in short children [J].
Achermann, JC ;
Brook, CGD ;
Robinson, ICAF ;
Matthews, DR ;
Hindmarsh, PC .
CLINICAL ENDOCRINOLOGY, 1999, 50 (03) :301-308
[2]   Reduction of the pituitary GH releasable pool in short children with GH neurosecretory dysfunction [J].
Aimaretti, G ;
Bellone, S ;
Bellone, J ;
Chiabotto, P ;
Baffoni, C ;
Corneli, G ;
Origlia, C ;
de Sanctis, C ;
Camanni, F ;
Ghigo, E .
CLINICAL ENDOCRINOLOGY, 2000, 52 (03) :287-293
[3]   GROWTH-HORMONE SECRETORY RATES IN CHILDREN AS ESTIMATED BY DECONVOLUTION ANALYSIS OF 24-H PLASMA-CONCENTRATION PROFILES [J].
ALBERTSSONWIKLAND, K ;
ROSBERG, S ;
LIBRE, E ;
LUNDBERG, LO ;
GROTH, T .
AMERICAN JOURNAL OF PHYSIOLOGY, 1989, 257 (06) :E809-E814
[4]   EVIDENCE FOR PARTIAL GROWTH-HORMONE INSENSITIVITY AMONG PATIENTS WITH IDIOPATHIC SHORT STATURE [J].
ATTIE, KM ;
CARLSSON, LMS ;
RUNDLE, AC ;
SHERMAN, BM .
JOURNAL OF PEDIATRICS, 1995, 127 (02) :244-250
[5]   A dominant-negative mutation of the growth hormone receptor causes familial short stature [J].
Ayling, RM ;
Ross, R ;
Towner, P ;
VonLaue, S ;
Finidori, J ;
Moutoussamy, S ;
Buchanan, CR ;
Clayton, PE ;
Norman, MR .
NATURE GENETICS, 1997, 16 (01) :13-14
[6]   Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: Effect of growth hormone therapy [J].
Barreca, A ;
Bozzola, M ;
Cesarone, A ;
Steenbergh, PH ;
Holthuizen, PE ;
Severi, F ;
Giordano, G ;
Minuto, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (10) :3534-3541
[7]   THE METABOLIC-CLEARANCE, DISTRIBUTION, AND DEGRADATION OF DIMERIC AND MONOMERIC GROWTH-HORMONE (GH) - IMPLICATIONS FOR THE PATTERN OF CIRCULATING GH FORMS [J].
BAUMANN, G ;
STOLAR, MW ;
BUCHANAN, TA .
ENDOCRINOLOGY, 1986, 119 (04) :1497-1501
[8]   HETEROGENEITY OF CIRCULATING GROWTH-HORMONE [J].
BAUMANN, G ;
SHAW, M ;
AMBURN, K ;
JAN, T ;
DAVILA, N ;
MERCADO, M ;
STOLAR, M ;
MACCART, J .
NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (03) :369-379
[9]   GROWTH-HORMONE (GH) PROVOCATIVE TESTING FREQUENTLY DOES NOT REFLECT ENDOGENOUS GH SECRETION [J].
BERCU, BB ;
SHULMAN, D ;
ROOT, AW ;
SPILIOTIS, BE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 63 (03) :709-716
[10]   Reduced human growth hormone (hGH) bioactivity without a defect of the GH-1 gene in three patients with rhGH responsive growth failure [J].
Binder, G ;
Benz, MR ;
Elmlinger, M ;
Pflaum, CD ;
Strasburger, CJ ;
Ranke, MB .
CLINICAL ENDOCRINOLOGY, 1999, 51 (01) :89-95